Boon-Cher Goh
National University of Singapore · 76 works · 3,751 citations · h-index 30
Top works
- Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies
- Third generation EGFR TKIs: current data and future directions
- Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
- A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
- A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non–Small Cell Lung Cancer Patients
- Do STAT3 inhibitors have potential in the future for cancer therapy?
- Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies
- Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity
- Pharmacogenetics in Breast Cancer Therapy
- ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside
- Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3
- Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography–tandem mass spectrometry
- Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial
- Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway
- Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
- A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib
- Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
- An Expedient Assay for Determination of Gemcitabine and Its Metabolite in Human Plasma Using Isocratic Ion-Pair Reversed-Phase High-Performance Liquid Chromatography
- Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
- Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib